40.40 - 41.05
29.80 - 47.18
2.12M / 3.68M (Avg.)
18.02 | 2.27
View analysts' price targets and recommendations, and compare them with competitors.
$52.00
Lower upside than VET's upside of 42.44%.
Buy
Equal to VET's analyst recommendation of Buy.
Analyze analyst forecasts for the company and compare them with competitors.
9.39B
Better than VET's estimated revenue of 1.83B.
1.88B
Better than VET's estimated ebitda of 828.32M.
4.50
Better than VET's estimated eps of 1.10.
1.21B
Better than VET's estimated net income of 204.86M.
-28.33M
Worse than VET's estimated ebit of 231.12M.
1.63B
Worse than VET's estimated sg&a expense of 146.27M.
Analyze DCF forecasts for the company and compare them with competitors.
14.24B
Better than VET's revenue of 2.10B.
15.56%
Worse than VET's revenue growth rate of 17.50%.
2.85B
Better than VET's ebitda of 953.53M.
20.00%
Worse than VET's ebitda margin of 45.36%.
-42.96M
Worse than VET's ebit of 266.05M.
-0.30%
Worse than VET's ebit margin of 12.66%.
2.89B
Worse than VET's depreciation of 687.47M.
151.18M
Better than VET's total cash of 38.46M.
1.06%
Worse than VET's cash as percentage of revenue of 1.83%.
2.03B
Worse than VET's receivables of 263.30M.
14.23%
Worse than VET's receivables as percentage of revenue of 12.52%.
16.68M
Better than VET's inventories of 27.95M.
0.12%
Better than VET's inventories as percentage of revenue of 1.33%.
654.42M
Worse than VET's accounts payable of 299.67M.
4.60%
Better than VET's payables as percentage of revenue of 14.25%.
-3.57B
Better than VET's capital expenditure of -484.82M.
-25.11%
Better than VET's capex as percentage of revenue of -23.06%.
12.06%
Better than VET's weighted average cost of capital (wacc) of 13.24%.
16.87%
Worse than VET's cost of equity of 16.56%.
5.31%
Better than VET's cost of debt of 9.00%.
2.64
Worse than VET's beta of 2.58.
263.90M
Worse than VET's diluted shares outstanding of 163.72M.
6.68B
Worse than VET's total debt of 655.60M.
10.03B
Better than VET's total equity of 1.42B.
16.71B
Better than VET's total capital of 2.07B.
39.98%
Worse than VET's debt weighting of 31.64%.
60.02%
Worse than VET's equity weighting of 68.36%.
-39.29M
Worse than VET's ebiat of 179.10M.
-910.92M
Worse than VET's unlevered free cash flow of 383.01M.
0.50%
Worse than VET's long-term growth rate of 2.00%.
-12.22B
Worse than VET's terminal value of 5.64B.
-10.90B
Worse than VET's enterprise value of 4.55B.
6.68B
Worse than VET's net debt of 557.67M.
-17.58B
Worse than VET's equity value of 3.99B.
-66.63
Worse than VET's equity value per share of 24.38.
